Accessibility Menu
Arrow-Thin-Down
S&P 500
6,878.88
-0.4%
-29.98
Arrow-Thin-Down
DJI
48,977.92
-1.1%
-521.28
Arrow-Thin-Down
NASDAQ
22,668.21
-0.9%
-210.17
Arrow-Thin-Down
Bitcoin
$66,357.00
-0.3%
-$170.87
Arrow-Thin-Down
NFLX
$96.46
+14.0%
+$11.87
Arrow-Thin-Down
PSKY
$13.52
+20.9%
+$2.34
Arrow-Thin-Down
CRWV
$79.47
-18.6%
-$18.16
Arrow-Thin-Down
AAOI
$83.51
+55.5%
+$29.82
Arrow-Thin-Down
FIGS
$15.44
+23.8%
+$2.97
Arrow-Thin-Down
MARA
$8.94
+5.8%
+$0.49
Arrow-Thin-Down
AMZN
$210.08
+1.0%
+$2.16
Arrow-Thin-Down
GOOG
$311.73
+1.5%
+$4.58
Arrow-Thin-Down
META
$648.51
-1.3%
-$8.50
Arrow-Thin-Down
MSFT
$393.00
-2.2%
-$8.72
Arrow-Thin-Down
NVDA
$176.69
-4.4%
-$8.20
Arrow-Thin-Down
TSLA
$402.37
-1.5%
-$6.21
Most Active StocksDaily Stock GainersDaily Stock Losers

Can Optimer Optimize Shareholder Returns?

Optimer looks at some "strategic" moves.

By Dave Williamson – Feb 27, 2013 at 6:03PM EST

In the following video, Motley Fool health-care analyst David Williamson discusses Optimer's (NASDAQ: OPTR) 10% jump on word that the company will look into "strategic alternatives" in the midst of its current difficult times. David speculates that this means the company may be looking to sell, and he discusses who some potential buyers might be.

Read Next

About the Author

Dave Williamson
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
XMFGreenwave4
X@motleydavid

Stocks Mentioned

Pfizer Stock Quote
Pfizer
NYSE: PFE
$27.63
(+1.94%)+$0.53

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services